Violeta Fodina
Violeta Fodina has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Aigars Dzalbs
Clinic ‘iVF-Riga’, Riga, Latvia
2 shared publicationsNatalija Vedmedovska
Clinic ‘iVF-Riga’, Riga, Latvia
2 shared publicationsSanta Andersone
Clinic ‘iVF-Riga’, Riga, Latvia
2 shared publicationsAlesja Dudorova
Genetic laboratory, Clinic "IVF-Riga" , Riga , Latvia
1 shared publication- Anda Kivite-Urtane
Institute of Public Health, Riga Stradins University, Riga, Latvia
1 shared publication - Anna Miskova
Department of Obstetrics and Gynaecology, Riga Maternity Hospital, Riga, Latvia
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 36 (sup1) , 53-57
The outcomes after transfers of embryos with chromosomal mosaicism: a single reproductive medicine center experience at iVF Riga clinic
Aim: The aim of this study is to summarize the outcomes of transfers of mosaic embryos, which were classified according to guidelines and in strong collaboration of reproductologists, clinical geneticists and patients approved as suitable for transfer. Material and Methods: Retrospective data were collected from 70 patients from a private IVF center to whom embryos with mosaic changes in chromosomal material were transferred from 2015 to 2019. Results and Conclusion: Implantation outcomes and continuing pregnancies showed slight differences, when compared to fully normal embryos. Artifacts have to be differentiated from undeniable aberrations, and correct interpretation of results must be done with following patient counselling and prenatal testing if necessary.
- 1 December 2020
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 36 (sup1) , 53-57
Open AccessThe outcomes after transfers of embryos with chromosomal mosaicism: a single reproductive medicine center experience at iVF Riga clinic
Aim: The aim of this study is to summarize the outcomes of transfers of mosaic embryos, which were classified according to guidelines and in strong collaboration of reproductologists, clinical geneticists and patients approved as suitable for transfer. Material and Methods: Retrospective data were collected from 70 patients from a private IVF center to whom embryos with mosaic changes in chromosomal material were transferred from 2015 to 2019. Results and Conclusion: Implantation outcomes and continuing pregnancies showed slight differences, when compared to fully normal embryos. Artifacts have to be differentiated from undeniable aberrations, and correct interpretation of results must be done with following patient counselling and prenatal testing if necessary.
- Open Access
- 31 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (9) , 654
The Correlation Between Abnormal Uterine Artery Flow in the First Trimester and Genetic Thrombophilic Alteration: A Prospective Case-Controlled Pilot Study
Introduction. Evaluation of the first trimester uterine artery flow can predict the development of obstetrical complications. A genotype, making women prone to microthrombi. constitutes the main known susceptibility factor for anomalous development of placenta. Our aim was to study whether polymorphisms of 10 genes leading to blood clotting abnormalities are related to abnormal uterine artery blood flow in the first trimester, and may predict placenta-related diseases. Material and methods. In primary analyses we included 19 singleton pregnancies with abnormal blood flow in the uterine arteries during the first trimester of gestation, and 24 matched control with normal flow patterns. All patients were genotyped for sequence variations in F5, F2, F11, MTHFR, SERPINE-1, CYP4V2, SELE, GP6, angiotensinogen (AGT) and fibrinogen gamma (FGG) genes and followed up until delivery. Results. There were no differences between groups regarding selected sequence variations in any of these genes. The co-occurrence of several polymorphisms in the same patient was also not related to the blood flow patterns in the uterine arteries. Conclusions. Although we found certain trends of genetic polymorphisms being related to preeclampsia and fetal growth, we failed to find an association between clotting gene polymorphisms, single or in combination, with the abnormal uterine flow in the first trimester.
- 31 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (9) , 654
Open AccessThe Correlation Between Abnormal Uterine Artery Flow in the First Trimester and Genetic Thrombophilic Alteration: A Prospective Case-Controlled Pilot Study
Introduction. Evaluation of the first trimester uterine artery flow can predict the development of obstetrical complications. A genotype, making women prone to microthrombi. constitutes the main known susceptibility factor for anomalous development of placenta. Our aim was to study whether polymorphisms of 10 genes leading to blood clotting abnormalities are related to abnormal uterine artery blood flow in the first trimester, and may predict placenta-related diseases. Material and methods. In primary analyses we included 19 singleton pregnancies with abnormal blood flow in the uterine arteries during the first trimester of gestation, and 24 matched control with normal flow patterns. All patients were genotyped for sequence variations in F5, F2, F11, MTHFR, SERPINE-1, CYP4V2, SELE, GP6, angiotensinogen (AGT) and fibrinogen gamma (FGG) genes and followed up until delivery. Results. There were no differences between groups regarding selected sequence variations in any of these genes. The co-occurrence of several polymorphisms in the same patient was also not related to the blood flow patterns in the uterine arteries. Conclusions. Although we found certain trends of genetic polymorphisms being related to preeclampsia and fetal growth, we failed to find an association between clotting gene polymorphisms, single or in combination, with the abnormal uterine flow in the first trimester.
- Open Access
- 31 July 2019
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (sup1) , 18-23
The application of PGT-A for carriers of balanced structural chromosomal rearrangements
The aim of this study was to analyze differences in chromosomal aberrations and euploidy in embryos of each translocation type and gender of carrier in the case series of 10 couples with balanced translocations who underwent IVF with embryos trophectoderm (TE) biopsy and PGT-A to detect chromosomal aberrations. This is a Case Series (Retrospective study). In each case, controlled ovarian hyperstimulation, oocyte insemination with intracytoplasmic sperm injection (ICSI) and cultivation gave multiple blastocysts, that underwent trophectoderm (TE) biopsy with PGT-A analysis using aCGH and NGS. Number of total unbalanced translocations compared to the number of sporadic aneuploid embryos was 39.6% to 39.6% (50% to 50% of all 37 aneuploid embryos). The highest euploidy rate was in male carrier group – 26.7% and the lowest in the Robertsonian translocation carrier group – 18.2%. Sporadic aneuploidy – 68.2% was highest in Robertsonian translocation carrier group and lowest in female group – 11.1%. Chromosomal aberrations related to translocation were highest in female carrier group – 77.8% and lowest in Robertsonian translocation carrier group – 13.6%. Our study showed that expectancy of total embryo aneuploidy rates will be higher in carriers, than in people with normal karyotype. The prevalence of chromosomal aberrations related to translocation was 4.5 times higher in Reciprocal carrier group than in Robertsonian translocation carrier group. Among maternal and paternal carrier groups, the embryos from female carriers had the lowest euploidy rate, unbalanced translocation rate 4.7 times higher than in the male carrier group and higher total aneuploidy rates.
- 31 July 2019
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (sup1) , 18-23
Open AccessThe application of PGT-A for carriers of balanced structural chromosomal rearrangements
The aim of this study was to analyze differences in chromosomal aberrations and euploidy in embryos of each translocation type and gender of carrier in the case series of 10 couples with balanced translocations who underwent IVF with embryos trophectoderm (TE) biopsy and PGT-A to detect chromosomal aberrations. This is a Case Series (Retrospective study). In each case, controlled ovarian hyperstimulation, oocyte insemination with intracytoplasmic sperm injection (ICSI) and cultivation gave multiple blastocysts, that underwent trophectoderm (TE) biopsy with PGT-A analysis using aCGH and NGS. Number of total unbalanced translocations compared to the number of sporadic aneuploid embryos was 39.6% to 39.6% (50% to 50% of all 37 aneuploid embryos). The highest euploidy rate was in male carrier group – 26.7% and the lowest in the Robertsonian translocation carrier group – 18.2%. Sporadic aneuploidy – 68.2% was highest in Robertsonian translocation carrier group and lowest in female group – 11.1%. Chromosomal aberrations related to translocation were highest in female carrier group – 77.8% and lowest in Robertsonian translocation carrier group – 13.6%. Our study showed that expectancy of total embryo aneuploidy rates will be higher in carriers, than in people with normal karyotype. The prevalence of chromosomal aberrations related to translocation was 4.5 times higher in Reciprocal carrier group than in Robertsonian translocation carrier group. Among maternal and paternal carrier groups, the embryos from female carriers had the lowest euploidy rate, unbalanced translocation rate 4.7 times higher than in the male carrier group and higher total aneuploidy rates.
- 5 October 2015
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 31 (sup1) , 51-54
How to decrease EPL rate treating infertility?
Early pregnancy loss (EPL) is the most common complication of early pregnancy and has a negative impact on the couple’s reproductive experience, including depression and anxiety disorders. Embryo selection is one of the most important steps in achieving success of ART treatment. Selection of high implantation potency embryo can improve treatment outcome and decrease EPL and multiple pregnancy rate implementing selective single embryo transfer (SET). One of the noninvasive embryo selection methods is time-lapse based morphokinetic (TLM) evaluation of the embryonic development. So, the objective of the study was to compare EPL rate between conservative embryo cultivation/selection and TLM groups. Longitudinal cohort study of 376 couples undergoing ICSI cycles in private reproductology clinic iVF Riga was performed. Logistic regression analysis adjusted by age and autologous oocyte in TLM assessment and control group was done, so there were no statistically significant differences in biochemical, clinical and ongoing pregnancy rates per ET, but EPL rate per ET was still statistically significantly reduced: OR 0.41, 95%CI 0.17–0.98, p = 0.044. TLM embryo culturing and selection method is safe, reliable and noninvasive strategy for improvement ongoing pregnancy rate and decreasing EPL rates for patient undergoing infertility treatment.
- 5 October 2015
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 31 (sup1) , 51-54
How to decrease EPL rate treating infertility?
Early pregnancy loss (EPL) is the most common complication of early pregnancy and has a negative impact on the couple’s reproductive experience, including depression and anxiety disorders. Embryo selection is one of the most important steps in achieving success of ART treatment. Selection of high implantation potency embryo can improve treatment outcome and decrease EPL and multiple pregnancy rate implementing selective single embryo transfer (SET). One of the noninvasive embryo selection methods is time-lapse based morphokinetic (TLM) evaluation of the embryonic development. So, the objective of the study was to compare EPL rate between conservative embryo cultivation/selection and TLM groups. Longitudinal cohort study of 376 couples undergoing ICSI cycles in private reproductology clinic iVF Riga was performed. Logistic regression analysis adjusted by age and autologous oocyte in TLM assessment and control group was done, so there were no statistically significant differences in biochemical, clinical and ongoing pregnancy rates per ET, but EPL rate per ET was still statistically significantly reduced: OR 0.41, 95%CI 0.17–0.98, p = 0.044. TLM embryo culturing and selection method is safe, reliable and noninvasive strategy for improvement ongoing pregnancy rate and decreasing EPL rates for patient undergoing infertility treatment.